Intertrust NV
LSE:0RCL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Intertrust NV
LSE:0RCL
|
NL |
|
Healthia Ltd
ASX:HLA
|
AU |
|
L
|
Lucid Diagnostics Inc
NASDAQ:LUCD
|
US |
|
J Sainsbury PLC
F:SUY
|
UK |
|
E
|
Elbit Systems Ltd
SWB:EB2
|
IL |
|
W
|
Watsco Inc
XMUN:WC3
|
US |
|
C
|
CPI Property Group SA
F:O5G
|
LU |
|
A
|
Archrock Inc
F:54E
|
US |
Wall St Price Targets
0RCL Price Targets Summary
Intertrust NV
According to Wall Street analysts, the average 1-year price target for 0RCL is 23.69 EUR with a low forecast of 20.95 EUR and a high forecast of 27.22 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0RCL's stock price target?
Price Target
23.69
EUR
According to Wall Street analysts, the average 1-year price target for 0RCL is 23.69 EUR with a low forecast of 20.95 EUR and a high forecast of 27.22 EUR.
What is the Revenue forecast for Intertrust NV?
Projected CAGR
2%
Over the last 11 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is 2%.
What is the Operating Income forecast for Intertrust NV?
Projected CAGR
1%
Over the last 11 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 3 years is 1%.
What is the Pre-Tax Income forecast for Intertrust NV?
Projected CAGR
2%
Over the last 11 years, the compound annual growth rate for Pre-Tax Income has been 5%. The projected CAGR for the next 3 years is 2%.
What is the Net Income forecast for Intertrust NV?
Projected CAGR
2%
Over the last 11 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 3 years is 2%.
